Self-nonself Recognition through B-Cell Antigen Receptor
- 841 Downloads
Receptors on innate immune cells that recognize pathogens, such as Toll-like receptors, have been diversified and selected through evolution. In contrast, antigen receptors on B and T lymphocytes diversify enormously in each individual: genes for these receptors composed of multiple various parts are assembled randomly through gene recombination during development of these cells throughout the life of the individuals. While T-cell antigen receptor (TCR) recognizes antigenic peptides of proteins presented on the self MHC, B-cell antigen receptor (BCR) recognizes essentially any kinds of molecules. It is miraculous that only a few genes generate a repertoire of receptors that match essentially all of the molecular structures existing on earth including even newly generated chemical compounds, the mechanisms for which have mostly been clarified to date as briefly mentioned below. It is also amazing that each of the enormous number of receptors recognizes almost single specific structure. Another surprise is that such diverse receptors in an individual do not react with any structures contained in the self body (self-antigens) in principle, which is called self-tolerance.
KeywordsReceptor Editing Guanyl Nucleotide Exchange Factor
Unable to display preview. Download preview PDF.
- Dal Porto JM, Haberman AM, Kelsoe G, Shlomchik MJ (2002) Very low affinity B cells form germinal centers, become memory B cells, and participate in secondary immune responses when higher affinity competition is reduced. J Exp Med 195:1215–1221Google Scholar
- Franzoso G, Carlson L, Poljak L, Shores E, Epstein S, Leonardi A, Grinberg A, Tran T, Scharton-Kersten T, Anver M, et al (1998) Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med 187:147–159PubMedGoogle Scholar
- Fujikawa K, Miletic AV, Alt FW, Faccio R, Brown T, Hoog J, Fredericks J, Nishi S, Mildiner S, Moores SL, et al (2003) Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells. J Exp Med 198:1595–1608PubMedGoogle Scholar
- Grumont RJ, Rourke IJ, O’Reilly LA, Strasser A, Miyake K, Sha W, Gerondakis S (1998) B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogenactivated cells. J Exp Med 187:663–674PubMedGoogle Scholar
- Horikawa K, Martin SW, Pogue SL, Silver K, Peng K, Takatsu K, Goodnow CC (2007) Enhancement and suppression of signaling by the conserved tail of IgG memory-type B-cell antigen receptors. J Exp MedGoogle Scholar
- Kraus M, Pao L, Reichlin A, Hu Y, Canono B, Cambier J, Nussenzweig M, Rajewsky K (2001) Interference with immunoglobulin (Ig)alpha immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B-cell development, depending on the availability of an Igbeta cytoplasmic tail. J Exp Med 194:455–469PubMedGoogle Scholar
- Lang J, Arnold B, Hammerling G, Harris AW, Korsmeyer S, Russell D, Strasser A, Nemazee D (1997) Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J Exp Med 186:1513–1522PubMedGoogle Scholar
- Nagaoka H, Takahashi Y, Hayashi R, Nakamura T, Ishii K, Matsuda J, Ogura A, Shirakata Y, Karasuyama H, Sudo T, et al (2000) Ras mediates effector pathways responsible for pre-B-cell survival, which is essential for the developmental progression to the late pre-B-cell stage. J Exp Med 192:171–182PubMedGoogle Scholar
- Nishina H, Bachmann M, Oliveira-dos-Santos AJ, Kozieradzki I, Fischer KD, Odermatt B, Wakeham A, Shahinian A, Takimoto H, Bernstein A, et al (1997) Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes. J Exp Med 186:941–953PubMedGoogle Scholar